Tag: therapeutics
March 30, 2019
New to the Investing News Network
Here at the Investing News Network our mission is twofold; to provide the latest news and quality education by helping... March 13, 2019
NervGen Pharma Completes $10 Million Initial Public Offering; Shares to Commence Trading on TSX-V on March 15, 2019 – Symbol “NGEN”
NervGen Pharma Corp. ("NervGen" or the "Company"), a regenerative medicine company dedicated to creating innovative solutions for the treatment of... December 31, 2018
New to the Investing News Network
Here at the Investing News Network our mission is twofold; to provide the latest news and quality education by helping...
November 25, 2018
What is In-licensing?
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
November 13, 2018
CRISPR Trials to Watch in 2018
CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
November 12, 2018
Why Invest in Nanotech Stocks?
Nanotech benefits areas as diverse as cancer therapies and solar energy solutions. Here's why you should consider nanotech stocks.
November 5, 2018